Arkolith/Insider Trading/PRME/Form 4

ARCH Venture Fund XII, L.P.

10% OwnerPrime Medicine, Inc. (PRME) · full profile →Form 4 · filed Aug 1, 2025
Net Buying
Open-Market Buys
$10.0M
Open-Market Sells
$0
Net Open-Market Flow
$10.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 1, 2025Buy(P)3.0M$3.30$10.0M6.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-25-013461) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML